The invention relates to microorganisms for the treatment of food allergies, specifically coeliac disease, as well as to methods for the selection thereof. The action mechanisms of said microorganisms include: (i) the regulation of the innate and adaptive immunological response； (ii) the reduction of the concentration of toxic epitopes in the intestinal lumen； (iii) the strengthening of the barrier defense function against harmful antigens and bacteria； and (iv) the provision of enzymatic activities that promote digestion.
